Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia	Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting	Recruiting	Not stated	2025-01-01		NCT06756022

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Anhui Provincial Children's Hospital	6

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Children's Hospital	Hefei	China	1

Clinical trials